> top > docs > PMC:7696151 > spans > 30044-30389 > annotations

PMC:7696151 / 30044-30389 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
904 66-74 Species denotes patients Tax:9606
947 139-142 Chemical denotes HCQ MESH:D006886
948 154-157 Chemical denotes AZM MESH:D017963
949 328-331 Chemical denotes HCQ MESH:D006886
950 336-339 Chemical denotes AZM MESH:D017963
987 48-56 Disease denotes COVID-19 MESH:C000657245
988 57-65 Disease denotes infected MESH:D007239

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T207 0-345 Sentence denotes In particular, a prospective study on 11 severe COVID-19 infected patients treated with the same dosage used by Gautret et al. (600 mg/day HCQ and 500 mg AZM for the first day followed by 250 mg/day from day 2 to 5) was shown to provide no evidence of clinical benefits or a strong antiviral activity through the combination of HCQ and AZM [34].